Johnson & Johnson (JNJ) Financials

JNJ Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2026 ? ?
June 30, 2026 201.1 billion 116.1 billion
March 31, 2026 200.9 billion 119.7 billion
Dec. 31, 2025 199.2 billion 117.7 billion

JNJ Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 ? ?
June 30, 2026 3.4 billion 458.0 million
March 31, 2026 1.5 billion 300.0 million
Dec. 31, 2025 5.5 billion 309.0 million

JNJ Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Sept. 30, 2026 ?
June 30, 2026 5.5 billion
March 31, 2026 5.2 billion
Dec. 31, 2025 5.1 billion

JNJ Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 - - -
June 30, 2026 20.8 billion 37.3 billion -
March 31, 2026 22.1 billion 37.5 billion -
Dec. 31, 2025 20.1 billion 39.4 billion -

JNJ Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2026 2.4 billion
June 30, 2026 2.4 billion
March 31, 2026 2.4 billion
Dec. 31, 2025 2.4 billion

JNJ Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 - 4.7 billion 6.3 billion -
June 30, 2026 1.3 billion 3.7 billion 6.4 billion -
March 31, 2026 1.0 billion 3.5 billion 6.0 billion -
Dec. 31, 2025 1.8 billion 4.3 billion 6.8 billion -

JNJ Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 25.4 billion 6.9 billion
June 30, 2026 25.3 billion 8.1 billion
March 31, 2026 24.1 billion 8.1 billion
Dec. 31, 2025 24.6 billion 8.0 billion

JNJ Revenue by Segment

Graph available only for paid members. Upgrade to see it.

JNJ

List: Champions

Price: $271.22

52 week price:
180.59
286.56

Dividend Yield: 0.51%

5-year range yield:
0.51%
3.37%

Forward Dividend Yield: 1.98%

Payout Ratio: 75.04%

Payout Ratio Range:
-4326.47%
1561.77%

Dividend Per Share: 5.36 USD

Earnings Per Share: 6.59 USD

P/E Ratio: 38.78

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 6.9 million

Ebitda: 2.9 billion

Market Capitalization: 615.9 billion

Average Dividend Frequency: 4

Years Paying Dividends: 26

DGR3: 4.92%

DGR5: 5.25%

DGR10: 5.71%

DGR20: 7.24%

Links: